Systemic lupus erythematosus with paraproteinemia

Area of Science:

• Immunology
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by polyclonal B cell activation.
• The presence of monoclonal (M) proteins in SLE patients requires further investigation regarding its clinical significance.

Purpose of the Study:

• To investigate the prevalence and characteristics of monoclonal (M) proteins in patients with systemic lupus erythematosus (SLE).
• To determine any potential correlation between M proteins and SLE disease activity or related conditions.

Main Methods:

• A longitudinal prospective study followed 415 patients with SLE.
• Monoclonal proteins in serum were identified and characterized (IgG, IgA, IgM).
• Patients were assessed for signs of plasmacytic dyscrasia, Bence Jones proteinuria, malignancy, and SLE disease activity.

Main Results:

• Nine out of 415 SLE patients (2.2%) presented with monoclonal (M) proteins.
• The M proteins identified were IgG (6 patients), IgA (2 patients), and IgM (1 patient).
• No evidence of plasmacytic dyscrasia, Bence Jones proteinuria, or malignancy was found. No correlation was observed between M protein presence/type/concentration and SLE activity markers.

Conclusions:

• Monoclonal proteins are present in a small subset of SLE patients.
• The presence of M proteins in SLE does not appear to be associated with disease activity or malignancy.
• Further research is warranted to understand the relationship between M proteins, B cell activation, and therapeutic interventions in SLE.